Oncolytics Biotech® Announces Phase 1b Data Demonstrating Clinical Proof-of-Concept for Pelareorep-Proteasome Inhibitor Combination in Multiple Myeloma in an Abstract at the AACR Annual Meeting

March 9, 2022

ZenaTech’s National Drone as a Service (DaaS) Grows Through Closing a Fifth Acquisition, Adding Powerline Inspection Capabilities

May 22, 2025
Today’s Stock Market in 2-Minutes

May 22, 2025
Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Assay for Residual Cancer and Recurrence Detection

May 22, 2025
JZXN Announces Major Strategic Move: Acquisition of 1,000 Bitcoins Over the Next Year

May 22, 2025